chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 14.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Throat irritation
Clinical narrative: Patient received vaccine at Health dept 5/13/2021 at 4pm.  Presented to our office 5/14/21. seen by Dr 3:09 pm, complaint that had facial burning 1-2 hours after first dose COVID vaccine.  School nurse called and reported face swollen and throat itching took Benadryl and did not help.   no cough or wheeze, throat itchy called and spoke allergist who stated did not expect allergic run to last that long and people will idiopathic urticaria can have reactivation of urticaria- VAERS Report filed yesterday Patient returned to Saturday walk in clinic today 5/15/21 and saw me-  woke up at 2 AM c/o difficulty breathing but didn't want to bother parents on arrival 09:29 P130 sat 98%- nurses state not in distress at arrival  at my arrival in room 10:20 AM noted to have frank stridor and fair to good air movement- patient seems to have worsened while here 0.3 mg Epi given IM and felt better sent to ER by ambulance - Hospital for additional monitoring? in case more epi needed
Age: 14.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Burning sensation, Dyspnoea, Stridor, Swelling face, Throat irritation
Clinical narrative: Patient received vaccine at Health dept 5/13/2021 at 4pm.  Presented to our office 5/14/21. seen by Dr 3:09 pm, complaint that had facial burning 1-2 hours after first dose COVID vaccine.  School nurse called and reported face swollen and throat itching took Benadryl and did not help.   no cough or wheeze, throat itchy called and spoke allergist who stated did not expect allergic run to last that long and people will idiopathic urticaria can have reactivation of urticaria- VAERS Report filed yesterday Patient returned to Saturday walk in clinic today 5/15/21 and saw me-  woke up at 2 AM c/o difficulty breathing but didn't want to bother parents on arrival 09:29 P130 sat 98%- nurses state not in distress at arrival  at my arrival in room 10:20 AM noted to have frank stridor and fair to good air movement- patient seems to have worsened while here 0.3 mg Epi given IM and felt better sent to ER by ambulance - Hospital for additional monitoring? in case more epi needed
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Injection site reaction, Myalgia, Pruritus
Clinical narrative: Red rash at injection site (about 2"), itching, aching joints, overall muscle aches, over tired
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous
Clinical narrative: Red rash at injection site (about 2"), itching, aching joints, overall muscle aches, over tired
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, Lymphadenopathy, Rash
Clinical narrative: Full body rash, swollen lymph nodes, hair loss
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site mass, Injection site pruritus, Injection site rash, Injection site warmth
Clinical narrative: Big red itchy rash at the injection site, skin is raised and feels like a big lump under the skin. Started mid-day and has gotten progressively itchier and warm to the touch.  Circular in shape and around 2 inches diameter.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Rash papular
Clinical narrative: Big red itchy rash at the injection site, skin is raised and feels like a big lump under the skin. Started mid-day and has gotten progressively itchier and warm to the touch.  Circular in shape and around 2 inches diameter.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: Mixed bacterostatic sodium chloride instead of sterile sodium chloride with pfizer vaccine and inject into patient. Waiting for CDC recommendations on how to move forward before contacting patient.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: Mixed bacterostatic sodium chloride instead of sterile sodium chloride with pfizer vaccine and inject into patient. Waiting for CDC recommendations on how to move forward before contacting patient.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: Mixed bacterostatic sodium chloride instead of sterile sodium chloride with pfizer vaccine and inject into patient. Waiting for CDC recommendations on how to move forward before contacting patient.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Mixed bacterostatic sodium chloride instead of sterile sodium chloride with pfizer vaccine and inject into patient. Waiting for CDC recommendations on how to move forward before contacting patient.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Mixed bacterostatic sodium chloride instead of sterile sodium chloride with pfizer vaccine and inject into patient. Waiting for CDC recommendations on how to move forward before contacting patient.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Loss of consciousness
Clinical narrative: Called and asked to assist in the vaccine clinic.  Patient vaccinated at approximately 1620, reaction at 1630  Patient sitting on the floor complaining of being light headed.  Patient reports feeling better and is able to converse without difficulty.  Patient moved to a chair on her own accord and after approximately one minute patient began to lose consciousness.  BP taken and was reported at 56/35 and was placed on 4L of O2.  Patient did not respond well and was transitioned to O2 per facemask at 10 L and paramedics called.  Patient transferred to stretcher and patient regained consciousness.  Patient able to speak.  VS taken by team and BS taken and was WNL. Patient declined ER visit, but remained in vaccine clinic for additional 30 minutes until 1715.  Patient left clinic ambulatory in stable condition without incident.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Audiogram, Deafness neurosensory
Clinical narrative: Sudden sensorineural hearing loss in right ear 1.5 months after receiving 2nd dose
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: Mixed bacterostatic sodium chloride instead of sterile sodium chloride with pfizer vaccine and inject into patient. Waiting for CDC recommendations on how to move forward before contacting patient.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Arthritis, Fibromyalgia, Nerve injury
Clinical narrative: I developed a task all over my body the day after I got my 1 shot.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Angina pectoris, Dyspnoea
Clinical narrative: Angina  Shortness of breath
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: Mixed bacterostatic sodium chloride instead of sterile sodium chloride with pfizer vaccine and inject into patient. Waiting for CDC recommendations on how to move forward before contacting patient.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Blood potassium decreased, Blood thyroid stimulating hormone, Chest X-ray normal, Computerised tomogram thorax, Dizziness
Clinical narrative: 2 days after vaccine developed constant buzzing & jittering.  3 days after vaccine to ER for arm numbness & tingling.  7 days after vaccine to ER for dizziness & shortness of breath.  10 days after vaccine saw me in clinic with ongoing tremor/jitteriness.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Electrocardiogram normal, Feeling jittery, Hypoaesthesia, Paraesthesia
Clinical narrative: 2 days after vaccine developed constant buzzing & jittering.  3 days after vaccine to ER for arm numbness & tingling.  7 days after vaccine to ER for dizziness & shortness of breath.  10 days after vaccine saw me in clinic with ongoing tremor/jitteriness.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus, Tremor, Troponin I normal
Clinical narrative: 2 days after vaccine developed constant buzzing & jittering.  3 days after vaccine to ER for arm numbness & tingling.  7 days after vaccine to ER for dizziness & shortness of breath.  10 days after vaccine saw me in clinic with ongoing tremor/jitteriness.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Balance disorder, Condition aggravated, Dizziness, Ear discomfort, Hyperhidrosis
Clinical narrative: Dizziness, unbalance. Vertigo was there occasionally the first couple days for hours or minutes, continues endlessly for now. I had a case of vertigo 8 or 9 years ago but no issues ever again with the ear or hearing or balance. After the first shot I twice thought I had a blockage or something in the ear. Tried drops, wax remover whatever you can find, nothing helped. Eventually it subsided but never gave real vertigo or long lasting balance issue. After 2nd shot was immediately an issue. Constant sweating and 99.5 fever for the 11th, 12th and 13th. 3 days straight of just sweating. Vomiting on around or just after midnight on the 13th, into the morning of the 14th. End of the 14th leading to the 15th the Veritgo has a light migraine attached. The migraine is mostly in the right eye has any migraine I've had is, comes with some light nasal pressure right at the eye socket. No issues with nasal drip or stuffy nose. Slight blurred vision which either creates the migraine or is from it. I also had migraines in the past but no more than 1 a year for the last 5 years, nothing I have medication or treatment for any longer.  This vertigo has a low grade migraine with small dot of blurred vision from one eye, my right eye. I dance with my daughter which is usually holding hands and spinning until her feet come off the ground. The first recognition that something is terribly wrong in my ear was that the moment I spin I can't rotate more than once rapidly without becoming incredibly unstably dizzy. That regardless of the vertigo, migraine or anything has been true since the 2nd shot when I spin I am at a total loss of balance.  There is constant dizziness, blurred vision, migraine
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Migraine, Nasal inflammation, Pyrexia, Vertigo, Vision blurred
Clinical narrative: Dizziness, unbalance. Vertigo was there occasionally the first couple days for hours or minutes, continues endlessly for now. I had a case of vertigo 8 or 9 years ago but no issues ever again with the ear or hearing or balance. After the first shot I twice thought I had a blockage or something in the ear. Tried drops, wax remover whatever you can find, nothing helped. Eventually it subsided but never gave real vertigo or long lasting balance issue. After 2nd shot was immediately an issue. Constant sweating and 99.5 fever for the 11th, 12th and 13th. 3 days straight of just sweating. Vomiting on around or just after midnight on the 13th, into the morning of the 14th. End of the 14th leading to the 15th the Veritgo has a light migraine attached. The migraine is mostly in the right eye has any migraine I've had is, comes with some light nasal pressure right at the eye socket. No issues with nasal drip or stuffy nose. Slight blurred vision which either creates the migraine or is from it. I also had migraines in the past but no more than 1 a year for the last 5 years, nothing I have medication or treatment for any longer.  This vertigo has a low grade migraine with small dot of blurred vision from one eye, my right eye. I dance with my daughter which is usually holding hands and spinning until her feet come off the ground. The first recognition that something is terribly wrong in my ear was that the moment I spin I can't rotate more than once rapidly without becoming incredibly unstably dizzy. That regardless of the vertigo, migraine or anything has been true since the 2nd shot when I spin I am at a total loss of balance.  There is constant dizziness, blurred vision, migraine
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Dizziness, unbalance. Vertigo was there occasionally the first couple days for hours or minutes, continues endlessly for now. I had a case of vertigo 8 or 9 years ago but no issues ever again with the ear or hearing or balance. After the first shot I twice thought I had a blockage or something in the ear. Tried drops, wax remover whatever you can find, nothing helped. Eventually it subsided but never gave real vertigo or long lasting balance issue. After 2nd shot was immediately an issue. Constant sweating and 99.5 fever for the 11th, 12th and 13th. 3 days straight of just sweating. Vomiting on around or just after midnight on the 13th, into the morning of the 14th. End of the 14th leading to the 15th the Veritgo has a light migraine attached. The migraine is mostly in the right eye has any migraine I've had is, comes with some light nasal pressure right at the eye socket. No issues with nasal drip or stuffy nose. Slight blurred vision which either creates the migraine or is from it. I also had migraines in the past but no more than 1 a year for the last 5 years, nothing I have medication or treatment for any longer.  This vertigo has a low grade migraine with small dot of blurred vision from one eye, my right eye. I dance with my daughter which is usually holding hands and spinning until her feet come off the ground. The first recognition that something is terribly wrong in my ear was that the moment I spin I can't rotate more than once rapidly without becoming incredibly unstably dizzy. That regardless of the vertigo, migraine or anything has been true since the 2nd shot when I spin I am at a total loss of balance.  There is constant dizziness, blurred vision, migraine
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chest pain, Pain in extremity, Sleep disorder
Clinical narrative: Child was complaining of pain and knot on the left side of her chest and her left shoulder and arm as well. Parent took child to the doctor on May 12, 2021 because the pain was unbearable. The doctor stated to the parent that she needs to consulted with the infections disease doctor to get his opinion on what it is and how to treat it. The infections disease doctor stated to the other doctor to treat it with antibiotics. The doctor wanted to do a follow-up with child in two to three days to see if the antibiotics is working.  Childs follow-up is schedule for May 15, 2021. Child was saying that she cannot sleep on her left side because it hurts so much.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Hyperventilation, Tremor
Clinical narrative: Uncontrollable  shaking, chills, hyperventilating, diarrhea
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus, Injection site rash, Injection site swelling
Clinical narrative: May 14th, 2021 at approximately 23:00 I started getting a rash/raised lesion on my left arm at the injection site, which wasn't painful-just itchy. It went away after a while and is fine now.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Pain in extremity
Clinical narrative: Severe and chronic arm pain at and around injection site lasting more than 2 and a half weeks
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Peripheral swelling, Pruritus, Skin warm
Clinical narrative: The first day, I had slight arm soreness with nothing more. When I woke up on day two, I noticed my arm had swelled more than usual (basing off my previous dose in my right arm) and was extremely hot, tender, and had two circular red patches. That night, the redness and swelling had spread into a medium sized circle, and began to itch and still be very hot upon touch. Upon looking later that night, at approximately 11pm EST, the swelling and redness had gotten larger.  On day three, the redness only got worse, and is slowly spread more over the area, with intense itching, but no longer is as sore as it was the day prior. I have iced the area, moved my arm around more to help the swelling go down, taken a hot shower, and about 600mg of Ibuprofen each day since the second dose. The only outcome to those treatments has been a significant decrease in pain level, but the swelling and redness still continues. This has all been over about a 48-72 hour time period
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Muscular weakness, Paraesthesia
Clinical narrative: 15 minutes after shot left leg and foot feel asleep. 30 minutes after shot started experiencing intermittent pins and needles sensations through out entire body (legs, feet, arms, hands and top lip). Right hand and arm would fall asleep randomly and loose strength. Various parts of body would feel numb to the touch, (back of calves, stomach, cheek). 1 week later and still experiencing these symptoms intermittently throughout the day after my  second dose of Pfizer.  Note, first dose of Pfizer I only experienced sore arm. Second dose is when what I presume to be nerve issues arose.
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Thrombosis
Clinical narrative: BLOOD CLOTS 16APRIL
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: Covid arm. Swelling, itching, heat at site of injection.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site induration, Injection site reaction, Injection site swelling, Injection site warmth, Rash macular
Clinical narrative: Left upper arm has raised reddish blotches beneath the vaccination site (shoulder). They do not itch, but they are warm to the touch. Arm beneath them is slightly hard and swollen. I noticed them the night of 5/14, but it's possible they were present earlier - I wasn't looking at the arm from a few hours after the vaccination (afternoon of 5/13) until now.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Hyperaesthesia, Ocular discomfort, Photophobia, Sunburn
Clinical narrative: Extreme sensitivity to sunlight. Patient normally spends many hours a day outside doing various activities exposed to sunlight without getting a sun burn. The day after vaccine and since the patient can be outside for as short as 10-20 minutes and skin becomes visibly red and begins to quickly sun burn severely as if she was outside in direct sunlight for many,many hours. Eyes have also become very sensitive to sunlight requiring the use of sunglasses even indoors in a bright room. Causing great discomfort and unable to focus. Has previously never experienced these issues.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Vision blurred
Clinical narrative: Extreme sensitivity to sunlight. Patient normally spends many hours a day outside doing various activities exposed to sunlight without getting a sun burn. The day after vaccine and since the patient can be outside for as short as 10-20 minutes and skin becomes visibly red and begins to quickly sun burn severely as if she was outside in direct sunlight for many,many hours. Eyes have also become very sensitive to sunlight requiring the use of sunglasses even indoors in a bright room. Causing great discomfort and unable to focus. Has previously never experienced these issues.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Nausea
Clinical narrative: nausea and heed ache
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Dysgeusia, Hypoaesthesia
Clinical narrative: Five days after receiving my first dose of the Moderna vaccine, I experience some numbness in the 4th and 5th fingers of my left arm, which was the arm of injection.  I also experience the beginnings of a strange metallic taste in my mouth.  Sort of an iron/zinc/copper taste in my mouth that tainted the flavor of the morning cup of coffee and the other things I ate.  I thought it might be something wrong with me -- like some sort of cancer or something, but saw that others had experience the same symptom.  The taste sensation disappeared on 5/10/2021, a month after my second dose of my COVID-19.  I am still am experiencing episodic numbness in the 4th and 5th fingers on my left hand.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Syncope
Clinical narrative: patient felt dizzy and started to pass out (syncope) and was asked for pharmacist to lie in supine position so that circulation can be asissted (in the pharmacy waiting area). Patient started feeling better as soon as patient was lying down on the ground as was able to answer questions - was fully awake and aware of her surrondings. patient was then observed for 30 minutes and there were no further signs of adverse events. Pharmacist contacted the patient later durin the day and the patient was doing fine.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary mass, Lymphadenopathy, Pain in extremity
Clinical narrative: Swelling under arm, when I woke up Friday I noticed under my arm is pretty painful , I can feel what I would describe as a lump right in my armpit. Just started Friday . I am going to see how it is over the weekend.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain
Clinical narrative: Chronic lower back pain lasting for 3 weeks.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymphnodes.  Went away by 5/15; however I did not hear of this being g a side effect and thought I should report it.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain, Pruritus, Skin warm, Swelling
Clinical narrative: Very swollen itchy red hot and painful
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Herpes zoster without complication
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Muscle twitching, Throat tightness
Clinical narrative: Severe headache,  Swollen throat.  Twitching.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Hyperhidrosis, Hypoaesthesia, Pallor
Clinical narrative: Following the injection, client reported feeling faint, sweaty and numbness in hands. Client appears diaphoretic and pale.  Client was sat on the floor in the recovery position. Initial vitals: 100/55, 97,98% O2.   Second set of vitals @05:05pm: 111/51, 73, 20, 98%.  Reassessment @ 5:15pm: calm, breathing at 18 breaths per min.  Remained for further observation sitting upright in chair for additional 15 minutes. Discharge set of vitals @ 5:36pm: 120/72, 16, 60 99%.  Departed clinic on his own accord.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram pulmonary abnormal, Atelectasis, Blood potassium decreased, C-reactive protein increased, Computerised tomogram head abnormal
Clinical narrative: On 5/13/2021 patient developed a cough in the evening. Patient woke up not feeling well on 5/14/2021, and also had nausea and vomiting. Patient was driving a vehicle when he had a seizure. No prior history of seizures. Drifted off the road, no significant damage to vehicle. Patient post-ictal following seizure, seizure activity was witnessed by bystanders. CT brain showed small subdural hematoma. A CTA chest performed due to hypoxemia and tachycardia at Hospital  showed Multifocal groundglass type nodular infiltrates throughout the right lung involving the upper lobe, middle lobe, and lower lobe, minimal left lower lobe patchy infiltrate, as well as patient's known thymoma. These multifocal groundglass infiltrates were not previously mentioned on a CT chest performed on 4/10/2021.  Patient was transferred to this facility for evaluation by neurosurgery. Patient was mildly tachycardic, hypoxemic to 88% on room air, and tachypneic. Patient reported decreased sense of taste & smell for 1 month, which he attributed to his losartan use.  A covid/flu/rsv PCR on 4/10/2021 was negative, and a viral respiratory pathogen panel with covid PCR was negative on 5/14/2021, as was an antigen & NAAT for COVID on 5/14/2021.  Patient was treated with antibiotics and admitted for further management.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram thorax abnormal, Cough, Full blood count, Hypogeusia, Hyposmia
Clinical narrative: On 5/13/2021 patient developed a cough in the evening. Patient woke up not feeling well on 5/14/2021, and also had nausea and vomiting. Patient was driving a vehicle when he had a seizure. No prior history of seizures. Drifted off the road, no significant damage to vehicle. Patient post-ictal following seizure, seizure activity was witnessed by bystanders. CT brain showed small subdural hematoma. A CTA chest performed due to hypoxemia and tachycardia at Hospital  showed Multifocal groundglass type nodular infiltrates throughout the right lung involving the upper lobe, middle lobe, and lower lobe, minimal left lower lobe patchy infiltrate, as well as patient's known thymoma. These multifocal groundglass infiltrates were not previously mentioned on a CT chest performed on 4/10/2021.  Patient was transferred to this facility for evaluation by neurosurgery. Patient was mildly tachycardic, hypoxemic to 88% on room air, and tachypneic. Patient reported decreased sense of taste & smell for 1 month, which he attributed to his losartan use.  A covid/flu/rsv PCR on 4/10/2021 was negative, and a viral respiratory pathogen panel with covid PCR was negative on 5/14/2021, as was an antigen & NAAT for COVID on 5/14/2021.  Patient was treated with antibiotics and admitted for further management.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia, Impaired driving ability, Lung infiltration, Lung opacity, Magnetic resonance imaging head
Clinical narrative: On 5/13/2021 patient developed a cough in the evening. Patient woke up not feeling well on 5/14/2021, and also had nausea and vomiting. Patient was driving a vehicle when he had a seizure. No prior history of seizures. Drifted off the road, no significant damage to vehicle. Patient post-ictal following seizure, seizure activity was witnessed by bystanders. CT brain showed small subdural hematoma. A CTA chest performed due to hypoxemia and tachycardia at Hospital  showed Multifocal groundglass type nodular infiltrates throughout the right lung involving the upper lobe, middle lobe, and lower lobe, minimal left lower lobe patchy infiltrate, as well as patient's known thymoma. These multifocal groundglass infiltrates were not previously mentioned on a CT chest performed on 4/10/2021.  Patient was transferred to this facility for evaluation by neurosurgery. Patient was mildly tachycardic, hypoxemic to 88% on room air, and tachypneic. Patient reported decreased sense of taste & smell for 1 month, which he attributed to his losartan use.  A covid/flu/rsv PCR on 4/10/2021 was negative, and a viral respiratory pathogen panel with covid PCR was negative on 5/14/2021, as was an antigen & NAAT for COVID on 5/14/2021.  Patient was treated with antibiotics and admitted for further management.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Mediastinal mass, Nausea, Neutrophil percentage increased, Platelet count normal
Clinical narrative: On 5/13/2021 patient developed a cough in the evening. Patient woke up not feeling well on 5/14/2021, and also had nausea and vomiting. Patient was driving a vehicle when he had a seizure. No prior history of seizures. Drifted off the road, no significant damage to vehicle. Patient post-ictal following seizure, seizure activity was witnessed by bystanders. CT brain showed small subdural hematoma. A CTA chest performed due to hypoxemia and tachycardia at Hospital  showed Multifocal groundglass type nodular infiltrates throughout the right lung involving the upper lobe, middle lobe, and lower lobe, minimal left lower lobe patchy infiltrate, as well as patient's known thymoma. These multifocal groundglass infiltrates were not previously mentioned on a CT chest performed on 4/10/2021.  Patient was transferred to this facility for evaluation by neurosurgery. Patient was mildly tachycardic, hypoxemic to 88% on room air, and tachypneic. Patient reported decreased sense of taste & smell for 1 month, which he attributed to his losartan use.  A covid/flu/rsv PCR on 4/10/2021 was negative, and a viral respiratory pathogen panel with covid PCR was negative on 5/14/2021, as was an antigen & NAAT for COVID on 5/14/2021.  Patient was treated with antibiotics and admitted for further management.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Postictal state, Respiratory viral panel, Respirovirus test positive, SARS-CoV-2 test negative, Scan with contrast abnormal
Clinical narrative: On 5/13/2021 patient developed a cough in the evening. Patient woke up not feeling well on 5/14/2021, and also had nausea and vomiting. Patient was driving a vehicle when he had a seizure. No prior history of seizures. Drifted off the road, no significant damage to vehicle. Patient post-ictal following seizure, seizure activity was witnessed by bystanders. CT brain showed small subdural hematoma. A CTA chest performed due to hypoxemia and tachycardia at Hospital  showed Multifocal groundglass type nodular infiltrates throughout the right lung involving the upper lobe, middle lobe, and lower lobe, minimal left lower lobe patchy infiltrate, as well as patient's known thymoma. These multifocal groundglass infiltrates were not previously mentioned on a CT chest performed on 4/10/2021.  Patient was transferred to this facility for evaluation by neurosurgery. Patient was mildly tachycardic, hypoxemic to 88% on room air, and tachypneic. Patient reported decreased sense of taste & smell for 1 month, which he attributed to his losartan use.  A covid/flu/rsv PCR on 4/10/2021 was negative, and a viral respiratory pathogen panel with covid PCR was negative on 5/14/2021, as was an antigen & NAAT for COVID on 5/14/2021.  Patient was treated with antibiotics and admitted for further management.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Seizure, Subdural haematoma, Tachycardia, Tachypnoea, Vomiting
Clinical narrative: On 5/13/2021 patient developed a cough in the evening. Patient woke up not feeling well on 5/14/2021, and also had nausea and vomiting. Patient was driving a vehicle when he had a seizure. No prior history of seizures. Drifted off the road, no significant damage to vehicle. Patient post-ictal following seizure, seizure activity was witnessed by bystanders. CT brain showed small subdural hematoma. A CTA chest performed due to hypoxemia and tachycardia at Hospital  showed Multifocal groundglass type nodular infiltrates throughout the right lung involving the upper lobe, middle lobe, and lower lobe, minimal left lower lobe patchy infiltrate, as well as patient's known thymoma. These multifocal groundglass infiltrates were not previously mentioned on a CT chest performed on 4/10/2021.  Patient was transferred to this facility for evaluation by neurosurgery. Patient was mildly tachycardic, hypoxemic to 88% on room air, and tachypneic. Patient reported decreased sense of taste & smell for 1 month, which he attributed to his losartan use.  A covid/flu/rsv PCR on 4/10/2021 was negative, and a viral respiratory pathogen panel with covid PCR was negative on 5/14/2021, as was an antigen & NAAT for COVID on 5/14/2021.  Patient was treated with antibiotics and admitted for further management.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: White blood cell count increased
Clinical narrative: On 5/13/2021 patient developed a cough in the evening. Patient woke up not feeling well on 5/14/2021, and also had nausea and vomiting. Patient was driving a vehicle when he had a seizure. No prior history of seizures. Drifted off the road, no significant damage to vehicle. Patient post-ictal following seizure, seizure activity was witnessed by bystanders. CT brain showed small subdural hematoma. A CTA chest performed due to hypoxemia and tachycardia at Hospital  showed Multifocal groundglass type nodular infiltrates throughout the right lung involving the upper lobe, middle lobe, and lower lobe, minimal left lower lobe patchy infiltrate, as well as patient's known thymoma. These multifocal groundglass infiltrates were not previously mentioned on a CT chest performed on 4/10/2021.  Patient was transferred to this facility for evaluation by neurosurgery. Patient was mildly tachycardic, hypoxemic to 88% on room air, and tachypneic. Patient reported decreased sense of taste & smell for 1 month, which he attributed to his losartan use.  A covid/flu/rsv PCR on 4/10/2021 was negative, and a viral respiratory pathogen panel with covid PCR was negative on 5/14/2021, as was an antigen & NAAT for COVID on 5/14/2021.  Patient was treated with antibiotics and admitted for further management.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Insomnia, Tinnitus
Clinical narrative: Low humming noise in head.  Very hard to sleep and stay asleep. Finally visited doctor (my doctor was out of office) on 3-30 to discuss and see if ok to get 2nd dose. He called CDC and came back saying they said ok and looked at ears and routine checks and said ears looked fine, referred me to ENT. 2nd vaccine on 4-8-21.  Later same day humming changed to a loud high pitch noise 24/7. Visited doctor ENT on 4-14-21, he put me on 24 days, starting at 80 mg daily for 5 days with slow weening off of Prednisone.  Finished medicine with no changes but experienced awful side effects from steroids.  Next visit to doctor will be 5-24-21. Will also have a hearing test same day.  I have also been having dizzy spells.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain
Clinical narrative: Chest Pain almost daily for the past 2 weeks since getting my vaccine dose. It started within the first hour of getting the vaccine. I?ve had the chest pain almost daily regardless of food/rest/hydration/stress levels/heart rate.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Hot flush, Hyperhidrosis
Clinical narrative: I?ve been having extreme hot flashes/sweats upon the slightest exertion ie; walk, after taking shower. I have to sit  for awhile until it subsides or in front of a fan.  I have been through menopause years ago so these are not from that. I have not sought a doctors advice as of now.  I am hoping this problem goes away.......
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Intervertebral disc degeneration, Nerve compression, Pain in extremity, X-ray abnormal
Clinical narrative: About 24 hours after my second shot severe pain in back an lower extremities. Lasted at the severe level for about 12 hours. Mild pain continued for 2 weeks like sciatica nerve pain in both legs.  2 and a half weeks later pinched nerve in back . L5 to S1.  Disc degeneration found but unexplained why the pain started at time of shot.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Injection site is not only painful but also swollen and warm. ?COVID arm?
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary mass
Clinical narrative: Small lump accompanied by medium to mild soreness going from left armpit to the back
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Acoustic stimulation tests normal, Blood test normal, Deafness, Ear, nose and throat examination, Magnetic resonance imaging head normal
Clinical narrative: Sudden 100% hearing loss right ear.  Severe Tenitus
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Physical examination, Tinnitus
Clinical narrative: Sudden 100% hearing loss right ear.  Severe Tenitus
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Injected limb mobility decreased, Injection site pain
Clinical narrative: Sharp pains in upper arm at the site of the injection; loss of range of motion; severe sharp pain when reaching, stretching left arm and shoulder.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia
Clinical narrative: Loss my sense of taste completely the day after I received my second vaccine. As of today it's been 20 days, no change in symptom.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chest pain, Facial paralysis, Hot flush, Muscle spasms
Clinical narrative: facial drop; chest pains/pressureweakness of limbshot face(no fever)facial dropmuscle spasmtingling in arms and faceswelling of throat(could still swallow/breath/speak); chest pains/pressure; chest pains/pressure; weakness of limbs; hot face (no fever); chest pains/pressureweakness of limbshot face(no fever)facial dropmuscle spasmtingling in arms and faceswelling of throat(could still swallow/breath/speak); tingling in arms and face; This is a spontaneous report from a contactable consumer.  A non-pregnant 27-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection),  dose 1 via an unspecified route of administration, administered on left arm on 24Mar2021 (Batch/Lot Number: EP7534) as 1st dose, single (at the age of 27 years old) for COVID-19 immunisation. The patient medical history included prior to vaccination, was the patient diagnosed with COVID-19?:Yes.  The patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered on left arm on 24Mar2021 (Batch/Lot Number: EP7534) for COVID-19 immunisation. he patient's concomitant medications were not reported.  The patient experienced chest pains/pressure, weakness of limbs, hot face (no fever), facial drop, muscle spasm, tingling in arms and face and swelling of throat (could still swallow/breath/speak) on 01Apr2021 03:00. The patient received benadryl and saline solution. The patient was tested for as nasal swab and the result was negative on 21Apr2021. The outcome of the events was recovering. The patient received dose 2 via an unspecified route of administration, administered on right arm on 14Apr2021 (Batch/Lot Number: pfizer EW0162).   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Muscular weakness, Paraesthesia, Pharyngeal swelling, SARS-CoV-2 test
Clinical narrative: facial drop; chest pains/pressureweakness of limbshot face(no fever)facial dropmuscle spasmtingling in arms and faceswelling of throat(could still swallow/breath/speak); chest pains/pressure; chest pains/pressure; weakness of limbs; hot face (no fever); chest pains/pressureweakness of limbshot face(no fever)facial dropmuscle spasmtingling in arms and faceswelling of throat(could still swallow/breath/speak); tingling in arms and face; This is a spontaneous report from a contactable consumer.  A non-pregnant 27-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection),  dose 1 via an unspecified route of administration, administered on left arm on 24Mar2021 (Batch/Lot Number: EP7534) as 1st dose, single (at the age of 27 years old) for COVID-19 immunisation. The patient medical history included prior to vaccination, was the patient diagnosed with COVID-19?:Yes.  The patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered on left arm on 24Mar2021 (Batch/Lot Number: EP7534) for COVID-19 immunisation. he patient's concomitant medications were not reported.  The patient experienced chest pains/pressure, weakness of limbs, hot face (no fever), facial drop, muscle spasm, tingling in arms and face and swelling of throat (could still swallow/breath/speak) on 01Apr2021 03:00. The patient received benadryl and saline solution. The patient was tested for as nasal swab and the result was negative on 21Apr2021. The outcome of the events was recovering. The patient received dose 2 via an unspecified route of administration, administered on right arm on 14Apr2021 (Batch/Lot Number: pfizer EW0162).   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 0.5
Sex: U
Vaccine: RV5
Symptoms: Expired product administered, No adverse event
Clinical narrative: No additional AE reported; Caller states a dose that expired on 3/22/2021 was administered to a patient on 3/25/2021; This spontaneous report was received from a medical assistant  referring to a 6-month-old patient of unknown age and gender. The patient's pertinent medical history, concomitant therapies, drug reactions or allergies were not reported.  On 25-MAR-2021, the patient was vaccinated with an expired dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) at a dose of 2 milliliter, orally for prophylaxis  (lot number 1660666 has been verified to be valid, expiration date reported as and validated as 22-MAR-2021) (vaccination scheme and dose number  not reported) (expired product administered). No additional adverse event (AE) reported.
Sex: M
Vaccine: MMR
Symptoms: Blood test, Hypersensitivity, Mobility decreased, Oesophageal pain, Peripheral swelling
Clinical narrative: This spontaneous report has been received from a consumer via Pfizer, who was the patient's girlfriend, referring about a male patient of unknown age. Information about the patient's pertinent medical history, concurrent conditions, concomitant medications and previous drug reactions and allergies was not provided. On an unknown date in 1991 (reported also as "30 years ago"), the patient was vaccinated with a dose of a measles vaccine (manufacturer unknown) for prophylaxis (trade name, formulation, strength, dose, dose number, frequency, route of administration, anatomical location, lot number and expiration date were not provided). On an unknown date in 1991 (reported also as "30 years ago"), after the measles vaccine (manufacturer unknown) administration, the patient experienced an allergic reaction such as body rash that started in the patient's torso and under the patient's arms, spread up the patient's neck  and was red and itchy; there were some hives involved, as well. The hives extended to his neck, his shoulders, his body, his private parts, and his butt. The caller also reported that the patient's right hand was swelling and had swollen to at least 1 or 2 sizes bigger than normal. The patient's left hand was swollen too. It was reported that the patient had difficulty squeezing both hands into fists due to the swelling. It was reported that the patient also presented some irritation in throat (hypersensitivity). On an unknown date in 1991, the patient also experienced a burning sensation in esophagus (esophageal pain). Caller reported that the patient's primary care physician did take blood work but the patient's allergist said that the results of the bloodwork would probably not be relevant based on fact that the patient was on medication at the point that the labs were drawn. The reason for the medication was not specified. At the time of reporting, the outcome of the aforementioned events was not reported. The causal relationship between the measles vaccine (manufacturer unknown) and hypersensitivity and esophageal pain was not provided.
Sex: M
Vaccine: MMR
Symptoms: Rash, Rash erythematous, Rash pruritic, Throat irritation, Urticaria
Clinical narrative: This spontaneous report has been received from a consumer via Pfizer, who was the patient's girlfriend, referring about a male patient of unknown age. Information about the patient's pertinent medical history, concurrent conditions, concomitant medications and previous drug reactions and allergies was not provided. On an unknown date in 1991 (reported also as "30 years ago"), the patient was vaccinated with a dose of a measles vaccine (manufacturer unknown) for prophylaxis (trade name, formulation, strength, dose, dose number, frequency, route of administration, anatomical location, lot number and expiration date were not provided). On an unknown date in 1991 (reported also as "30 years ago"), after the measles vaccine (manufacturer unknown) administration, the patient experienced an allergic reaction such as body rash that started in the patient's torso and under the patient's arms, spread up the patient's neck  and was red and itchy; there were some hives involved, as well. The hives extended to his neck, his shoulders, his body, his private parts, and his butt. The caller also reported that the patient's right hand was swelling and had swollen to at least 1 or 2 sizes bigger than normal. The patient's left hand was swollen too. It was reported that the patient had difficulty squeezing both hands into fists due to the swelling. It was reported that the patient also presented some irritation in throat (hypersensitivity). On an unknown date in 1991, the patient also experienced a burning sensation in esophagus (esophageal pain). Caller reported that the patient's primary care physician did take blood work but the patient's allergist said that the results of the bloodwork would probably not be relevant based on fact that the patient was on medication at the point that the labs were drawn. The reason for the medication was not specified. At the time of reporting, the outcome of the aforementioned events was not reported. The causal relationship between the measles vaccine (manufacturer unknown) and hypersensitivity and esophageal pain was not provided.
Age: 46.0
Sex: F
Vaccine: MMR
Symptoms: Expired product administered, No adverse event
Clinical narrative: no additional AE to report/ What was the patient's response? Normal; the vaccine was administered to a patient/ vaccine given past expiration date; It was discovered after administration the vaccine had expired in March 2021/ Indicate at which point in the process the medication error occurred charting of med./ MA did not noticed date until she was charting details; This spontaneous report has been received from a nurse (the clinic supervisor) referring to a 46-year-old female patient. The patient's pertinent medical history, drug reactions, allergies, illness at the time of vaccination, or pre-existing conditions were not reported.  On 28-APR-2021, the patient was vaccinated in her left deltoid with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live recombinant human albumin (rha) (M-M-R II) 0.5 milliliters (ml) vial for prophylaxis (route of administration, dose number, and vaccination scheme frequency were not reported; lot number S006646 and expiration date 05-MAR-2021, which were verified as valid). Concomitant sterile diluent was used.   It was discovered after the administration of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) that the vaccine had expired in March 2021 (expired product administered).   The vaccine operator was a trained healthcare professional, a physician assistant (PA), also reported as a medical assistant (MA). According to the clinic supervisor, the MA did not notice the date until charting details (wrong technique in product usage process). The patient's response was normal, drug treatment was not required, and there were no additional adverse events to report.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect route of product administration
Clinical narrative: Gardasil was administered subcutaneously, not intramuscularly, as the person who did the injection in the hospital did not pay attention; This spontaneous report was received from a patient of unknown age and gender referring to themselves. No information was provided regarding the patient's historical conditions, previous drug reactions, allergies, concurrent conditions or concomitant medications.      On an unknown date, the patient was vaccinated with the first dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL), subcutaneously, for prophylaxis (formulation, dose, lot number and expiration date were not reported), rather than intramuscularly, as the person who did the injection in the hospital did not pay attention. The reporter wanted to know if this mistake prevented the efficiency of the vaccine and if the dose should de repeated.